Curevac Nv Stock Price Prediction
CVAC Stock | USD 2.87 0.13 4.74% |
Oversold Vs Overbought
41
Oversold | Overbought |
EPS Estimate Next Quarter (0.31) | EPS Estimate Current Year 0.8788 | EPS Estimate Next Year (0.51) | Wall Street Target Price 6.8945 | EPS Estimate Current Quarter 0.6 |
Using CureVac NV hype-based prediction, you can estimate the value of CureVac NV from the perspective of CureVac NV response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in CureVac NV to buy its stock at a price that has no basis in reality. In that case, they are not buying CureVac because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
CureVac NV after-hype prediction price | USD 2.89 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
CureVac |
CureVac NV After-Hype Price Prediction Density Analysis
As far as predicting the price of CureVac NV at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in CureVac NV or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of CureVac NV, with the unreliable approximations that try to describe financial returns.
Next price density |
Expected price to next headline |
CureVac NV Estimiated After-Hype Price Volatility
In the context of predicting CureVac NV's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on CureVac NV's historical news coverage. CureVac NV's after-hype downside and upside margins for the prediction period are 0.14 and 6.06, respectively. We have considered CureVac NV's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
CureVac NV is slightly risky at this time. Analysis and calculation of next after-hype price of CureVac NV is based on 3 months time horizon.
CureVac NV Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as CureVac NV is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading CureVac NV backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with CureVac NV, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.09 | 3.25 | 0.01 | 0.07 | 8 Events / Month | 5 Events / Month | In about 8 days |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.87 | 2.89 | 0.70 |
|
CureVac NV Hype Timeline
CureVac NV is currently traded for 2.87. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of 0.07. CureVac is forecasted to increase in value after the next headline, with the price projected to jump to 2.89 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 0.7%, whereas the daily expected return is currently at -0.09%. The volatility of related hype on CureVac NV is about 401.94%, with the expected price after the next announcement by competition of 2.94. The company reported the previous year's revenue of 53.76 M. Net Loss for the year was (260.17 M) with loss before overhead, payroll, taxes, and interest of (91.55 M). Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out CureVac NV Basic Forecasting Models to cross-verify your projections.CureVac NV Related Hype Analysis
Having access to credible news sources related to CureVac NV's direct competition is more important than ever and may enhance your ability to predict CureVac NV's future price movements. Getting to know how CureVac NV's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how CureVac NV may potentially react to the hype associated with one of its peers.
HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
CELH | Celsius Holdings | 1.85 | 9 per month | 0.00 | (0.16) | 5.82 | (5.33) | 20.47 | |
NCTW | Nascent Wine | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
MJWNY | Naked Wines plc | 0.00 | 0 per month | 0.00 | (0.05) | 0.00 | 0.00 | 14.59 | |
SNDL | SNDL Inc | 0.23 | 8 per month | 0.00 | (0.05) | 3.86 | (3.88) | 24.46 | |
DIN | Dine Brands Global | 2.54 | 10 per month | 2.80 | 0.01 | 4.71 | (4.50) | 19.97 | |
FIZZ | National Beverage Corp | (1.25) | 8 per month | 1.06 | (0.01) | 2.21 | (1.89) | 6.35 | |
PEP | PepsiCo | 2.29 | 6 per month | 0.00 | (0.25) | 1.24 | (1.38) | 6.65 |
CureVac NV Additional Predictive Modules
Most predictive techniques to examine CureVac price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for CureVac using various technical indicators. When you analyze CureVac charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About CureVac NV Predictive Indicators
The successful prediction of CureVac NV stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as CureVac NV, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of CureVac NV based on analysis of CureVac NV hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to CureVac NV's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to CureVac NV's related companies. 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 1.95 | 2.7 | 2.68 | 2.82 | Days Of Inventory On Hand | 86.06 | 47.59 | 72.79 | 132.4 |
Story Coverage note for CureVac NV
The number of cover stories for CureVac NV depends on current market conditions and CureVac NV's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that CureVac NV is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about CureVac NV's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
CureVac NV Short Properties
CureVac NV's future price predictability will typically decrease when CureVac NV's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of CureVac NV often depends not only on the future outlook of the potential CureVac NV's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. CureVac NV's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 220.8 M | |
Cash And Short Term Investments | 405.1 M |
Complementary Tools for CureVac Stock analysis
When running CureVac NV's price analysis, check to measure CureVac NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CureVac NV is operating at the current time. Most of CureVac NV's value examination focuses on studying past and present price action to predict the probability of CureVac NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CureVac NV's price. Additionally, you may evaluate how the addition of CureVac NV to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
CEOs Directory Screen CEOs from public companies around the world | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |